ecNumber*5.3.99.5#specificActivity*-999#specificActivityMaximum*#commentary*application of monoclonal antibodies to develop a tandem immunoradiometric assay#organism*Sus scrofa#literature*3165#!ecNumber*5.3.99.5#specificActivity*-999#specificActivityMaximum*#commentary*accumulation of thromboxane B2 in the culture supernatants of prostate cancer cells PC-3 1295 pg/ml compared with 580 pg/ml in supernatants from erythroleukemia cells HEL and 30 pg/ml from prostate cancer cells DU145. In cell lysates from PC-3 cells 22.5 pg thromboxane B2 per million cells, in cell lysates from prostate cancer cells DU145 0.475 pg per million cells#organism*Homo sapiens#literature*660657#!ecNumber*5.3.99.5#specificActivity*0.00515#specificActivityMaximum*#commentary*#organism*Sus scrofa#literature*3173#!ecNumber*5.3.99.5#specificActivity*0.231#specificActivityMaximum*#commentary*#organism*Sus scrofa#literature*3166#!ecNumber*5.3.99.5#specificActivity*0.255#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*3194#!ecNumber*5.3.99.5#specificActivity*0.259#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*3167#!ecNumber*5.3.99.5#specificActivity*1.15#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*3171#!ecNumber*5.3.99.5#specificActivity*2.95#specificActivityMaximum*#commentary*recombinant TXAS#organism*Homo sapiens#literature*651979#!ecNumber*5.3.99.5#specificActivity*24.1#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*3168#